competition law | Medicines Law & Policy

Strong call for transparency on medicine prices, cost of R&D at...

Ellen 't Hoen - April 19, 2019

Humiragate: AbbVie’s desperate attempts to keep its monopoly

Ellen 't Hoen - March 27, 2019

Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in...

Ellen 't Hoen - February 22, 2019

Time to put a stop to the abuse of orphan drug...

Ellen 't Hoen - January 9, 2019

2018 Round-up of Noteworthy Medicines Law and Policy Events

Ellen 't Hoen - December 26, 2018

Dutch health insurance company Menzis takes AstraZeneca to court over patent...

Ellen 't Hoen - September 20, 2018

New Dutch Foundation to Address High Medicines Pricing Announces Plan to...

Ellen 't Hoen - August 25, 2018

The Italian Exception – A personalised approach to accessing high-priced patented...

Ellen 't Hoen - May 5, 2017